Steward Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$19K Sell
594
-595
-50% -$21K 0.01% 260
2023
Q2
$43K Buy
+1,189
New +$46.3K 0.01% 161
2022
Q3
Sell
-544
Closed -$28K 972
2022
Q2
$28K Buy
544
+413
+315% +$21K 0.02% 141
2022
Q1
$6K Buy
131
+127
+3,175% +$6.59K 0.01% 231
2021
Q4
$0 Buy
+4
New +$198 ﹤0.01% 280

Other funds holding PFE

Steward Financial Group's PFE Position: Q3 2023 in Review

Steward Financial Group reduced its Pfizer (PFE) stake by 50% in Q3 2023, selling an estimated $21K and leaving 594 shares worth $19K. The position accounts for 0.01% of the portfolio, ranked #260.

Steward Financial Group first reported a position in PFE in Q4 2021 and has held it in 5 quarters since. The position peaked at $43K in Q2 2023. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

  • Steward Financial Group held 594 shares of Pfizer worth $19K as of Q3 2023.
  • Steward Financial Group sold 595 Pfizer shares in Q3 2023, an estimated $21K.
  • Pfizer made up 0.01% of Steward Financial Group's portfolio in Q3 2023, its #260 holding.
  • Steward Financial Group first reported a position in Pfizer in Q4 2021 and has held it in 5 quarters since.
  • Steward Financial Group's Pfizer position peaked at $43K in Q2 2023.
  • 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.